|
NRBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.07203176627991E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.91050003489823E-09 |
| Normal-vs-Stage2 |
5.923000E-03 |
| Normal-vs-Stage3 |
1.634960E-04 |
| Normal-vs-Stage4 |
2.606400E-01 |
| Stage1-vs-Stage2 |
8.050800E-01 |
| Stage1-vs-Stage3 |
1.348420E-01 |
| Stage1-vs-Stage4 |
5.113600E-01 |
| Stage2-vs-Stage3 |
1.865780E-01 |
| Stage2-vs-Stage4 |
7.191800E-01 |
| Stage3-vs-Stage4 |
2.140000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.07900022250362E-10 |
| Normal-vs-AfricanAmerican |
1.50660000031166E-07 |
| Normal-vs-Asian |
1.381160E-01 |
| Caucasian-vs-AfricanAmerican |
9.931000E-01 |
| Caucasian-vs-Asian |
4.419600E-01 |
| AfricanAmerican-vs-Asian |
4.434400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21709997635833E-09 |
| Normal-vs-Female |
3.64179797429642E-11 |
| Male-vs-Female |
3.097600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.198000E-03 |
| Normal-vs-Extreme_Weight |
8.10510000004427E-07 |
| Normal-vs-Obese |
9.60669999106045E-09 |
| Normal-vs-Extreme_Obese |
2.066800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.332180E-01 |
| Normal_Weight-vs-Obese |
6.998500E-03 |
| Normal_Weight-vs-Extreme_Obese |
7.318000E-01 |
| Extreme_Weight-vs-Obese |
1.453360E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.407600E-01 |
| Obese-vs-Extreme_Obese |
2.531200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.186840E-04 |
| Normal-vs-Age(41-60Yrs) |
1.17572618307804E-12 |
| Normal-vs-Age(61-80Yrs) |
3.18899999962596E-07 |
| Normal-vs-Age(81-100Yrs) |
2.253800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.836300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.183000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.024000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.478160E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.154400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.050800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.22044604925031E-14 |
| Normal-VS-Type2 PRCC |
1.804380E-02 |
| Normal-VS-KIRP CIMP |
2.015800E-04 |
| Normal-VS-Unclassified PRCC |
4.21019999999883E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.65629999999895E-05 |
| Type1 PRCC-VS-KIRP CIMP |
6.275500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.777400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.604500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.362600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.025600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.842980E-04 |
| Normal-vs-N1 |
8.819300E-04 |
| Normal-vs-N2 |
1.083760E-01 |
| N0-vs-N1 |
6.477900E-02 |
| N0-vs-N2 |
2.310600E-01 |
| N1-vs-N2 |
9.145200E-01 |
|
|
